口服缓释剂型的放大生产 - Suppr | 超能文献

Scaleup of oral extended-release dosage forms.

作者信息

Skelly J P, Van Buskirk G A, Arbit H M, Amidon G L, Augsburger L, Barr W H, Berge S, Clevenger J, Dighe S, Fawzi M

出版信息

Pharm Res. 1993 Dec;10(12):1800-5. doi: 10.1023/a:1018946819849.

DOI:10.1023/a:1018946819849

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Scaleup of oral extended-release dosage forms.口服缓释剂型的放大生产

Pharm Res. 1993 Dec;10(12):1800-5. doi: 10.1023/a:1018946819849.

2

Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations.工业用缓释固体口服剂型指南草案。体外-体内相关性的开发、评估和应用。

Adv Exp Med Biol. 1997;423:269-88. doi: 10.1007/978-1-4684-6036-0_25.

3

Terminology challenges: defining modified release dosage forms in veterinary medicine.术语挑战：定义兽医医学中的改良释放剂型。

J Pharm Sci. 2010 Aug;99(8):3281-90. doi: 10.1002/jps.22095.

4

Workshop II report: scaleup of oral extended release dosage forms.

J Pharm Sci Technol. 1994 Mar-Apr;48(2):95-101.

5

Generic omeprazole delayed-release capsules: in vitro performance evaluations.通用奥美拉唑延迟释放胶囊：体外性能评估。

Drug Dev Ind Pharm. 2009 Aug;35(8):917-21. doi: 10.1080/03639040802698802.

6

Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms.口服控释/缓释剂型体外和体内测试及相关性研讨会报告

J Pharm Sci. 1990 Sep;79(9):849-54. doi: 10.1002/jps.2600790923.

7

Selection of oral controlled-release drugs: a critical decision for the physician.口服控释药物的选择：医生的关键决策。

South Med J. 1993 Feb;86(2):208-14. doi: 10.1097/00007611-199302000-00013.

8

Scaleup of immediate release oral solid dosage forms.速释口服固体制剂的放大生产

Pharm Res. 1993 Feb;10(2):313-6. doi: 10.1023/a:1018915700942.

9

Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products.口服缓释制剂的生物利用度和生物等效性方面

AAPS J. 2017 Mar;19(2):360-366. doi: 10.1208/s12248-016-0025-9. Epub 2016 Dec 21.

10

Scale-up of immediate release oral solid dosage forms. AAPS/FDA Workshop Committee Report.速释口服固体制剂的扩大生产。美国药学科学家协会/美国食品药品监督管理局研讨会委员会报告。

J Parenter Sci Technol. 1993 Mar-Apr;47(2):52-6.

引用本文的文献

1

Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.在当前的质量源于设计范式下，红外（IR）和磁共振（MR）剂型的研发、放大生产及批准后变更控制的最佳实践。

AAPS PharmSciTech. 2014 Jun;15(3):665-93. doi: 10.1208/s12249-014-0087-x. Epub 2014 Mar 1.

2

A history of biopharmaceutics in the Food and Drug Administration 1968-1993.1968-1993 年美国食品和药物管理局的生物药剂学历史。

AAPS J. 2010 Mar;12(1):44-50. doi: 10.1208/s12248-009-9154-8. Epub 2009 Nov 20.

3

Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation.亲水性酒石酸美托洛尔缓释片制剂的体外-体内相关性的建立与内部验证

Pharm Res. 1998 Mar;15(3):466-73. doi: 10.1023/a:1011988601696.